ELASMOGEN LIMITED
Research and experimental development on biotechnology
ELASMOGEN LIMITED
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
Liberty Building Foresterhill Aberdeen AB25 2ZP
Full company profile for ELASMOGEN LIMITED (SC467513), an active life sciences and medical technology company based in Foresterhill, United Kingdom. Incorporated 15 Jan 2014. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2014–2024)
Cash in Bank
£2.31M
Net Assets
£2.81M
Total Liabilities
£282.86k
Turnover
N/A
Employees
17
Debt Ratio
9%
Financial History
Revenue, profit, EBITDA and key financial figures
2025 31 Jan Year End | 2024 31 Jan Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (6)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Jan 2016 | Seed |
| Investor 2 | Mar 2017 | Seed |
| Investor 3 | Mar 2017 | Seed |
See all 6 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 14 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Bgf Investment Management Limited
United Kingdom
- Significant Influence Or Control
Caroline Jane Barelle
Ceased 2 Jan 2018
Kcp Nominees Ltd
Ceased 29 Apr 2022
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 26 May 2026 | Capital | Allotment of shares (GBP 29.69797) on 30 Apr 2026 | |
| 21 Apr 2026 | Officers | Termination of Andrew Justin Radcliffe Porter as director on 31 Mar 2026 | |
| 3 Feb 2026 | Confirmation Statement | Confirmation statement made on 15 Jan 2026 with updates | |
| 28 Jan 2026 | Officers | Termination of Lucy Edwardes-Jones as director on 15 Jan 2026 | |
| 7 May 2025 | Accounts | Annual accounts made up to 31 Jan 2025 |
Allotment of shares (GBP 29.69797) on 30 Apr 2026
Termination of Andrew Justin Radcliffe Porter as director on 31 Mar 2026
Confirmation statement made on 15 Jan 2026 with updates
Termination of Lucy Edwardes-Jones as director on 15 Jan 2026
Annual accounts made up to 31 Jan 2025
Recent Activity
Latest Activity
Allotment of shares (GBP 29.69797) on 30 Apr 2026
1 weeks ago on 26 May 2026
Termination of Andrew Justin Radcliffe Porter as director on 31 Mar 2026
1 months ago on 21 Apr 2026
Confirmation statement made on 15 Jan 2026 with updates
4 months ago on 3 Feb 2026
Termination of Lucy Edwardes-Jones as director on 15 Jan 2026
4 months ago on 28 Jan 2026
Annual accounts made up to 31 Jan 2025
1 years ago on 7 May 2025